Inventor · disambiguated record
Steven C. Quay
Also filed as: QUAY STEVEN C · QUAY STEVEN CARL
93 granted patents·112 pending applications·4,191 citations·filing 1984–2025
99Inventor score
Top patents by PatentIndex Score
205 records- 0198US6667048B1Emulsion vehicle for poorly soluble drugsSONUS PHARMA INC·Filed 1999·Granted Dec 23, 2003·194 cites·21 claims
- 0298US6458373B1Emulsion vehicle for poorly soluble drugsSONUS PHARMA INC·Filed 1998·Granted Oct 1, 2002·269 cites·14 claims
- 0398US5393524AMethods for selecting and using gases as ultrasound contrast mediaSONUS PHARMA INC·Filed 1993·Granted Feb 28, 1995·253 cites·13 claims
- 0497US5558853APhase shift colloids as ultrasound contrast agentsSONUS PHARMA INC·Filed 1994·Granted Sep 24, 1996·187 cites·48 claims
- 0597US5409688AGaseous ultrasound contrast mediaSONUS PHARMA INC·Filed 1992·Granted Apr 25, 1995·227 cites·16 claims
- 0697US4687659ADiamide-DTPA-paramagnetic contrast agents for MR imagingSALUTAR INC·Filed 1984·Granted Aug 18, 1987·118 cites·27 claims
- 0796US12275684B2Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2024·Granted Apr 15, 2025·2 cites·98 claims
- 0896US12071391B2Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2023·Granted Aug 27, 2024·4 cites·44 claims
- 0996US11680036B1Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2022·Granted Jun 20, 2023·6 cites·22 claims
- 1096US11572334B2Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2022·Granted Feb 7, 2023·8 cites·22 claims
- 1196US6982282B2Emulsion vehicle for poorly soluble drugsSONUS PHARMA INC·Filed 2002·Granted Jan 3, 2006·69 cites·23 claims
- 1296US5558854AUltrasound contrast media comprising perfluoropentane and perfluorohexane gasSONUS PHARMA INC·Filed 1995·Granted Sep 24, 1996·143 cites·13 claims
- 1395US12281056B2Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2023·Granted Apr 22, 2025·1 cites·58 claims
- 1495US11261151B2Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2018·Granted Mar 1, 2022·9 cites·21 claims
- 1595US8501824B2Amino acid lipids and uses thereofQUAY STEVEN C·Filed 2011·Granted Aug 6, 2013·48 cites·27 claims
- 1695US7166575B2Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2002·Granted Jan 23, 2007·46 cites·19 claims
- 1795US6287521B1Methods and devices for obtaining and assaying mammary fluid samples for evaluating breast diseases, including cancerATOSSA HEALTHCARE INC·Filed 1998·Granted Sep 11, 2001·219 cites·18 claims
- 1895US5595723AMethod for preparing storage stable colloidsSONUS PHARMA INC·Filed 1993·Granted Jan 21, 1997·137 cites·31 claims
- 1995US5558855APhase shift colloids as ultrasound contrast agentsSONUS PHARMA INC·Filed 1993·Granted Sep 24, 1996·134 cites·22 claims
- 2093US7244709B2Compositions and methods for enhanced mucosal delivery of parathyroid hormoneNASTECH PHARM CO·Filed 2005·Granted Jul 17, 2007·26 cites·32 claims
- 2193US6660286B1Emulsion vehicle for poorly soluble drugsSONUS PHARMA INC·Filed 1999·Granted Dec 9, 2003·82 cites·22 claims
- 2293US5573751APersistent gaseous bubbles as ultrasound contrast mediaSONUS PHARMA INC·Filed 1994·Granted Nov 12, 1996·110 cites·22 claims
- 2393US5364613APolychelants containing macrocyclic chelant moietiesSIEVING PAUL F·Filed 1990·Granted Nov 15, 1994·185 cites·33 claims
- 2493US4758422AFerrioxamine paramagnetic contrast agents for MR imagingSALUTAR INC·Filed 1986·Granted Jul 19, 1988·40 cites·18 claims
- 2592US7030155B2Emulsion vehicle for poorly soluble drugsSONUS PHARMA INC·Filed 2002·Granted Apr 18, 2006·49 cites·30 claims
- 2692US5707607APhase shift colloids as ultrasound contrast agentsSONUS PHARMA INC·Filed 1995·Granted Jan 13, 1998·93 cites·6 claims
- 2792US5039511AAmyloidosis and alzheimer's disease diagnostic assay and reagents thereforSALUTAR INC·Filed 1990·Granted Aug 13, 1991·39 cites·4 claims
- 2891US7939505B2Amino acid lipids and uses thereofMARINA BIOTECH INC·Filed 2008·Granted May 10, 2011·17 cites·31 claims
- 2991US7157426B2Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2004·Granted Jan 2, 2007·40 cites·19 claims
- 3091US5707606APhase shift colloids as ultrasound contrast agentsSONUS PHARMA INC·Filed 1995·Granted Jan 13, 1998·87 cites·4 claims
- 3190US7435720B2Compositions and methods for enhanced mucosal delivery of parathyroid hormoneMDRNA INC·Filed 2006·Granted Oct 14, 2008·16 cites·5 claims
- 3290US7128877B2Methods and devices for obtaining and assaying mammary fluid samples for evaluating breast diseases, including cancerATOSSA HEALTHCARE INC·Filed 2003·Granted Oct 31, 2006·42 cites·14 claims
- 3390US6727280B2Method for treating colorectal carcinoma using a taxane/tocopherol formulationSONUS PHARMA INC·Filed 2002·Granted Apr 27, 2004·36 cites·42 claims
- 3489US6894026B1Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disordersATOSSA HEALTHCARE INC·Filed 2000·Granted May 17, 2005·25 cites·11 claims
- 3589US6444791B1Methods and compositions for the treatment of keratoconus using protease inhibitorsQUAY ENTPR LLC K·Filed 2000·Granted Sep 3, 2002·30 cites·6 claims
- 3689US4687658AMetal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imagingSALUTAR INC·Filed 1984·Granted Aug 18, 1987·77 cites·27 claims
- 3788US5798266AMethods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancerQUAY ENTERPRISES LLC K·Filed 1996·Granted Aug 25, 1998·92 cites·37 claims
- 3887US6887210B2Devices and methods for obtaining mammary fluid samples for evaluating breast diseases, including cancerATOSSA HEALTHCARE INC·Filed 2001·Granted May 3, 2005·114 cites·36 claims
- 3987US4859451AParamagnetic contrast agents for MR imagingSALUTAR INC·Filed 1986·Granted Aug 22, 1989·55 cites·17 claims
- 4086US7863245B2Compositions for enhanced epithelial permeation of neuropeptide Y for treating obesityNASTECH PHARM CO·Filed 2008·Granted Jan 4, 2011·6 cites·15 claims
- 4186US7186691B2Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2003·Granted Mar 6, 2007·22 cites·27 claims
- 4286US6245319B1Colloidal dispersions of perfluoropentaneSONUS PHARMA INC·Filed 2000·Granted Jun 12, 2001·16 cites·43 claims
- 4386US5039512ANMR imaging with paramagnetic polyvalent metal salts of poly-(acid-alkylene-amino)-alkanesSALUTAR INC·Filed 1987·Granted Aug 13, 1991·52 cites·13 claims
- 4484US7229966B2Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2004·Granted Jun 12, 2007·20 cites·41 claims
- 4584US6703513B1Production and use of derivatized homoserine lactonesQUAY ENTPR LLC K·Filed 2000·Granted Mar 9, 2004·17 cites·23 claims
- 4683US12479790B2Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2025·Granted Nov 25, 2025·0 cites·100 claims
- 4783US8877729B2Amino acid lipids and uses thereofMARINA BIOTECH INC·Filed 2013·Granted Nov 4, 2014·4 cites·20 claims
- 4883US6875420B1Method of ultrasound imagingAMERSHAM HEALTH AS·Filed 1997·Granted Apr 5, 2005·60 cites·1 claims
- 4983US6274713B1PolychelantsSALUTAR INC·Filed 1995·Granted Aug 14, 2001·74 cites·21 claims
- 5082US7186692B2Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesityNASTECH PHARM CO·Filed 2004·Granted Mar 6, 2007·15 cites·50 claims
Showing the top 50 of 205 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Steven C. Quay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →